Celemics, Inc. (KOSDAQ:331920)

South Korea · Delayed Price · Currency is KRW

9,860.00

-150.00 (-1.50%)

At close: Aug 11, 2026

212.03% (1Y)

Market Cap	110.25B +327.3%
Revenue (ttm)	4.97B -24.7%
Net Income	-7.84B
EPS	-960.08
Shares Out	11.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,615
Open	10,020.00
Previous Close	10,010.00
Day's Range	9,610.00 - 10,170.00
52-Week Range	2,535.00 - 19,840.00
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2010

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 331920

Full Company Profile

Financial Performance

Financial Statements